Table 2.
Predictive values and likelihood ratios of self-reported undetectable VL in overall CHIWOS cohort (n = 336)
PPV (95% CI) | NPV (95% CI) | LR+ (95% CI) | LR− (95% CI) | |||
---|---|---|---|---|---|---|
Laboratory-confirmed VL (from BC-CfE)a | ||||||
VL <50 copies/mL | VL ≥50 copies/mL | |||||
Self-report VL (from CHIWOS) | ||||||
Undetectable (i.e. <50 copies/mL) | 267 | 18 | 93.7 (90.2–96.2) | 80.4 (66.9–90.2) | 3.2 (2.1–4.6) | 0.05 (0.03–0.10) |
Detectable (i.e. ≥50 copies/mL) | 10 | 41 |
PPV positive predictive value, NPV negative predictive value, LR+ positive likelihood ratio, LR− negative likelihood ratio, 95% CI 95 percent confidence interval, VL viral load, BC-CfE BC Centre for Excellence in HIV/AIDS, CHIWOS Canadian HIV Women’s Sexual and Reproductive Health Cohort Study
aGold standard (True diagnosis)